Summary
Machine-generated summaryA German health insurance entity is inviting pharmaceutical companies to sign non-exclusive drug discount agreements under § 130a (8) or 130c (1) SGB V. The contract period typically runs from August 1, 2026, to July 31, 2028. This is not a public procurement under EU Directive 2014/24/EU or the GWB, as there is no competitive selection process. The conditions, including the discount rate, are fixed and non-negotiable for all partners. Any pharmaceutical entrepreneur as defined by § 4 (18) AMG can participate. To conclude the contract, applicants must request the documents from the contact point, sign them, and submit the required declarations. No estimated value is provided.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
View the official noticeSimilar tenders
Germany Deutsche Rentenversicherung Knappschaft-Bahn-See
Germany Heinrich-Heine-Universität Düsseldorf
Germany Vertragseinrichtungen der Prospitalia GmbH, Ulm
Germany Universitätsklinikum Münster
Germany AOK NordWest